
Maria Marvich
Examiner (ID: 9363)
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633, 1634, 1631, 1636 |
| Total Applications | 1459 |
| Issued Applications | 618 |
| Pending Applications | 253 |
| Abandoned Applications | 627 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7050677
[patent_doc_number] => 20050186564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Production of proteins'
[patent_app_type] => utility
[patent_app_number] => 11/099302
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7948
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20050186564.pdf
[firstpage_image] =>[orig_patent_app_number] => 11099302
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/099302 | Production of proteins | Apr 4, 2005 | Abandoned |
Array
(
[id] => 5246933
[patent_doc_number] => 20070243167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Novel Herpes Simplex Viruses'
[patent_app_type] => utility
[patent_app_number] => 11/547951
[patent_app_country] => US
[patent_app_date] => 2005-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11248
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243167.pdf
[firstpage_image] =>[orig_patent_app_number] => 11547951
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/547951 | Novel Herpes Simplex Viruses | Apr 4, 2005 | Abandoned |
Array
(
[id] => 7019427
[patent_doc_number] => 20050221446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-06
[patent_title] => 'Methods for producing hyaluronic acid in a Bacillus cell'
[patent_app_type] => utility
[patent_app_number] => 11/096190
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 19577
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 58
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20050221446.pdf
[firstpage_image] =>[orig_patent_app_number] => 11096190
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/096190 | Methods for producing hyaluronic acid in a Bacillus cell | Mar 30, 2005 | Abandoned |
Array
(
[id] => 906940
[patent_doc_number] => 07332341
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-19
[patent_title] => 'Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells'
[patent_app_type] => utility
[patent_app_number] => 11/095491
[patent_app_country] => US
[patent_app_date] => 2005-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 24119
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/332/07332341.pdf
[firstpage_image] =>[orig_patent_app_number] => 11095491
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/095491 | Methods for producing heterologous polypeptides in trichothecene-deficient filamentous fungal mutant cells | Mar 30, 2005 | Issued |
Array
(
[id] => 7136793
[patent_doc_number] => 20050181507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Gene delivery vectors with cell type specificity for mesenchymal stem cells'
[patent_app_type] => utility
[patent_app_number] => 11/083590
[patent_app_country] => US
[patent_app_date] => 2005-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12672
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181507.pdf
[firstpage_image] =>[orig_patent_app_number] => 11083590
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/083590 | Gene delivery vectors with cell type specificity for mesenchymal stem cells | Mar 17, 2005 | Abandoned |
Array
(
[id] => 7136651
[patent_doc_number] => 20050181417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'System for the rapid manipulation of nucleic acid sequenaces'
[patent_app_type] => utility
[patent_app_number] => 11/080810
[patent_app_country] => US
[patent_app_date] => 2005-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11090
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20050181417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11080810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/080810 | System for the rapid manipulation of nucleic acid sequenaces | Mar 15, 2005 | Abandoned |
Array
(
[id] => 5820507
[patent_doc_number] => 20060024820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Chromosome-based platforms'
[patent_app_type] => utility
[patent_app_number] => 11/082154
[patent_app_country] => US
[patent_app_date] => 2005-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 39720
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0024/20060024820.pdf
[firstpage_image] =>[orig_patent_app_number] => 11082154
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/082154 | Chromosome-based platforms | Mar 14, 2005 | Abandoned |
Array
(
[id] => 8846272
[patent_doc_number] => 08455453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Use of VEGF-D gene to prevent restenosis'
[patent_app_type] => utility
[patent_app_number] => 11/064769
[patent_app_country] => US
[patent_app_date] => 2005-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 13668
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11064769
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/064769 | Use of VEGF-D gene to prevent restenosis | Feb 23, 2005 | Issued |
Array
(
[id] => 6966507
[patent_doc_number] => 20050233404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Methods for the identification of inhibitors of cyclic nucleotide phosphodiesterase as antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/041553
[patent_app_country] => US
[patent_app_date] => 2005-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10784
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20050233404.pdf
[firstpage_image] =>[orig_patent_app_number] => 11041553
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/041553 | Methods for the identification of inhibitors of cyclic nucleotide phosphodiesterase as antibiotics | Jan 23, 2005 | Abandoned |
Array
(
[id] => 5046522
[patent_doc_number] => 20070265196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein'
[patent_app_type] => utility
[patent_app_number] => 10/587101
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16876
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587101 | Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein | Jan 20, 2005 | Abandoned |
Array
(
[id] => 5046522
[patent_doc_number] => 20070265196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein'
[patent_app_type] => utility
[patent_app_number] => 10/587101
[patent_app_country] => US
[patent_app_date] => 2005-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16876
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0265/20070265196.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587101
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587101 | Method of Modulating Pro-Inflammatory and Inflammatory Activity Mediated by C-Reactive Protein | Jan 20, 2005 | Abandoned |
Array
(
[id] => 7182948
[patent_doc_number] => 20050191317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Ghrelin-carrier conjugates'
[patent_app_type] => utility
[patent_app_number] => 11/037396
[patent_app_country] => US
[patent_app_date] => 2005-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23781
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20050191317.pdf
[firstpage_image] =>[orig_patent_app_number] => 11037396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/037396 | Ghrelin-carrier conjugates | Jan 18, 2005 | Abandoned |
Array
(
[id] => 6952211
[patent_doc_number] => 20050227305
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Methods for the identification of inhibitors of adenylosuccinate synthase as antibiotics'
[patent_app_type] => utility
[patent_app_number] => 11/034798
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13855
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20050227305.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034798 | Methods for the identification of inhibitors of adenylosuccinate synthase as antibiotics | Jan 12, 2005 | Abandoned |
Array
(
[id] => 6977951
[patent_doc_number] => 20050287669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Nucleic acid construct and expression vector for enhancing the production of recombinant protein, and method for the massive production of recombinant protein'
[patent_app_type] => utility
[patent_app_number] => 11/031483
[patent_app_country] => US
[patent_app_date] => 2005-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15118
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20050287669.pdf
[firstpage_image] =>[orig_patent_app_number] => 11031483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/031483 | Nucleic acid construct and expression vector for enhancing the production of recombinant protein, and method for the massive production of recombinant protein | Jan 9, 2005 | Abandoned |
Array
(
[id] => 7051290
[patent_doc_number] => 20050187177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-25
[patent_title] => 'Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery'
[patent_app_type] => utility
[patent_app_number] => 11/023020
[patent_app_country] => US
[patent_app_date] => 2004-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16067
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20050187177.pdf
[firstpage_image] =>[orig_patent_app_number] => 11023020
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/023020 | Directed apoptosis in COX-2 overexpressing cancer cells through expression targeted gene delivery | Dec 22, 2004 | Issued |
Array
(
[id] => 6914122
[patent_doc_number] => 20050177880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Nucleic acid isolated from the 5\' nontranslated region (5\'NTR) end of the human FGF-1 gene having IRES activity'
[patent_app_type] => utility
[patent_app_number] => 11/021066
[patent_app_country] => US
[patent_app_date] => 2004-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 11072
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0177/20050177880.pdf
[firstpage_image] =>[orig_patent_app_number] => 11021066
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/021066 | Nucleic acid isolated from the 5' nontranslated region (5'NTR) end of the human FGF-1 gene having IRES activity | Dec 21, 2004 | Abandoned |
Array
(
[id] => 6983349
[patent_doc_number] => 20050153419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-14
[patent_title] => 'Methods for producing cell lines stable in serum-free medium suspension culture'
[patent_app_type] => utility
[patent_app_number] => 11/019137
[patent_app_country] => US
[patent_app_date] => 2004-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15487
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20050153419.pdf
[firstpage_image] =>[orig_patent_app_number] => 11019137
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/019137 | Methods for producing cell lines stable in serum-free medium suspension culture | Dec 20, 2004 | Abandoned |
Array
(
[id] => 4468638
[patent_doc_number] => 07943303
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Method for engineering strand-specific nicking endonucleases from restriction endonucleases'
[patent_app_type] => utility
[patent_app_number] => 11/013260
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 12
[patent_no_of_words] => 9967
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 233
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943303.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013260
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013260 | Method for engineering strand-specific nicking endonucleases from restriction endonucleases | Dec 14, 2004 | Issued |
Array
(
[id] => 6996684
[patent_doc_number] => 20050136462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Method for engineering nicking enzymes'
[patent_app_type] => utility
[patent_app_number] => 11/013235
[patent_app_country] => US
[patent_app_date] => 2004-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12602
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20050136462.pdf
[firstpage_image] =>[orig_patent_app_number] => 11013235
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/013235 | Method for engineering nicking enzymes | Dec 14, 2004 | Abandoned |
Array
(
[id] => 5710516
[patent_doc_number] => 20060051861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Cell lines for use in increasing protein yield from a cell culture'
[patent_app_type] => utility
[patent_app_number] => 11/011299
[patent_app_country] => US
[patent_app_date] => 2004-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11482
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051861.pdf
[firstpage_image] =>[orig_patent_app_number] => 11011299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/011299 | Cell lines for use in increasing protein yield from a cell culture | Dec 13, 2004 | Abandoned |